Literature DB >> 1710352

A cell-type specific and enhancer-dependent silencer in the regulation of the expression of the human urokinase plasminogen activator gene.

R Cannio1, P S Rennie, F Blasi.   

Abstract

A transcriptional silencer has been identified in the 5' regulatory region of the human urokinase plasminogen activator (uPA) gene. This region is able to block transcription from the human u-PA as well as the rabbit beta-globin promoters in a cell type specific and orientation independent way. The silencer is enhancer dependent and is active in two cell lines (HeLa and CV-1) which produce little if any uPA, but not in the high uPA producer PC3. Silencing activity and enhancer dependence can be separated: the silencing activity has been localized to the DNA fragment -660 to -536, while the enhancer dependence is located in the -536 to -308 fragment. The DNA sequence of the silencer region contains an element that closely resembles the TGF-beta responsive negative element TIE.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710352      PMCID: PMC329434          DOI: 10.1093/nar/19.9.2303

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

Review 1.  Transcriptional repression of eukaryotic promoters.

Authors:  M Levine; J L Manley
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

2.  Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.

Authors:  V J Hearing; L W Law; A Corti; E Appella; F Blasi
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

3.  Induction of c-fos gene and protein by growth factors precedes activation of c-myc.

Authors:  R Müller; R Bravo; J Burckhardt; T Curran
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

4.  The human urokinase-plasminogen activator gene and its promoter.

Authors:  A Riccio; G Grimaldi; P Verde; G Sebastio; S Boast; F Blasi
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

5.  trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation.

Authors:  F C Lucibello; C Lowag; M Neuberg; R Müller
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

6.  Expression of cellular oncogenes in human prostatic carcinoma cell lines.

Authors:  A W Rijnders; J A van der Korput; G J van Steenbrugge; J C Romijn; J Trapman
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

7.  Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype.

Authors:  F D Gaylis; H N Keer; M J Wilson; H C Kwaan; A A Sinha; J M Kozlowski
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

8.  Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.

Authors:  G Grimaldi; P Di Fiore; E K Locatelli; J Falco; F Blasi
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

9.  Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.

Authors:  M P Stoppelli; P Verde; G Grimaldi; E K Locatelli; F Blasi
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

10.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.

Authors:  Y Sato; D B Rifkin
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  5 in total

1.  The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Authors:  Nunzia Montuori; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Valeria Visconte; Daniela Alfano; Ada Pesapane; Francesca Wanda Rossi; Salvatore Salzano; Guido Rossi; Pia Ragno
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

2.  Synergistic transcriptional activation of the mouse urokinase plasminogen activator (uPA) gene and of its enhancer activator protein 1 (AP1) site by cAMP and retinoic acid.

Authors:  R Mira-Y-Lopez; S Jaramillo; Y Jing
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  Intronic and flanking sequences are required to silence enhancement of an embryonic beta-type globin gene.

Authors:  N J Wandersee; R C Ferris; G D Ginder
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

4.  Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.

Authors:  U Reuning; O Wilhelm; T Nishiguchi; L Guerrini; F Blasi; H Graeff; M Schmitt
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

5.  Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor.

Authors:  K J Stacey; L F Fowles; M S Colman; M C Ostrowski; D A Hume
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.